A recent article in the Journal of the American Medical Association (JAMA) reported that the rate of uterine cancer among women having surgical procedures using morcellation was 1 woman out of 368. Since the recent FDA hearing was about morcellation and the risk of finding uterine leiomyosarcoma (LMS), some of the media have misinterpreted this […]
There is a lot of confusing information circulating about morcellation and uterine leiomyosarcoma in the media since the FDA hearing on this issue a few weeks ago. I plan to post my analysis of the information, in segments, over the next week or two. This first post provides commentary about the numbers used in research […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged FDA, fibroids, laparoscopic myomectomy, laparoscopy, LMS, Morcellation, morcellation risks, myomectomy, power morcellation, risk of LMS, risk of Uterine Leiomyosarcoma, robotic myomectomy
|
As many of you probably know by now, the FDA recently issued a warning saying that morcellation of fibroids during laparoscopic myomectomy (or during laparoscopic hysterectomy) should be avoided because of the risk of uterine leiomyosarcoma (uterine muscle wall cancer). I disagree with this decision (see reasons below) and ask that women who have benefitted […]
Disclaimer: The ideas, procedures and suggestions contained on this web site are not intended as a substitute for consulting with your physician. All matters regarding your health require medical supervision.